Literature DB >> 23535363

Interferon-γ promoter is hypermethylated in blood DNA from workers with confirmed diisocyanate asthma.

Bin Ouyang1, David I Bernstein, Zana L Lummus, Jun Ying, Louis-Philippe Boulet, André Cartier, Denyse Gautrin, Shuk-Mei Ho.   

Abstract

Risk factors have not been identified that determine susceptibility for development of diisocyanate-induced occupational asthma (DA). We hypothesized that diisocyanate (DI) exposure could modify gene promoter regions regulating transcription of cytokine mediators and thereby influence expression of DA. A cross-sectional study was designed to investigate the promoter methylation status of candidate genes in DI-exposed workers. Subjects consisted of 131 workers in three groups: 40 cases with DA confirmed by a positive specific inhalation challenge (SIC) (DA+), 41 exposed workers with lower respiratory symptoms and negative SIC (DA-), and 50 asymptomatic exposed workers (AWs). We studied four candidate genes (GSTM1, DUSP22, IFN-γ, and IL-4) for which altered promoter methylation has been previously investigated for relationships with a variety of other environmental exposures. Methylation status was determined using methylation-specific quantitative PCR performed on genomic DNA extracted from whole blood. Results showed that relative methylation of IFN-γ promoter was significantly increased in DA+ in comparison with both comparator groups (DA- and AW), and it exhibited good sensitivity (77.5%) and specificity (80%) for identifying DA workers in a multivariate predictive model after adjusting for type of DI exposure, smoking status, methacholine PC₂₀, and gender. IL-4 promoter was slightly less methylated only in DA+ compared with AW among nonsmoking workers. Both GSTM1 and DUSP22 promoter methylations were found not associated with DA. Our finding suggests that exposure to occupational chemicals could play a heretofore undefined mechanistic role via epigenetic modification of specific genes in the promoter region.

Entities:  

Keywords:  DNA methylation; IFN-γ; asthma; diisocyanate; environmental exposure; occupational asthma.

Mesh:

Substances:

Year:  2013        PMID: 23535363      PMCID: PMC3663564          DOI: 10.1093/toxsci/kft079

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  28 in total

Review 1.  Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement.

Authors:  Susan M Tarlo; John Balmes; Ronald Balkissoon; Jeremy Beach; William Beckett; David Bernstein; Paul D Blanc; Stuart M Brooks; Clayton T Cowl; Feroza Daroowalla; Philip Harber; Catherine Lemiere; Gary M Liss; Karin A Pacheco; Carrie A Redlich; Brian Rowe; Julia Heitzer
Journal:  Chest       Date:  2008-09       Impact factor: 9.410

2.  Glutathione S-transferase GSTP1 is a susceptibility gene for occupational asthma induced by isocyanates.

Authors:  Cristina E Mapp; Anthony A Fryer; Nicoletta De Marzo; Valeria Pozzato; Michele Padoan; Piera Boschetto; Richard C Strange; Anja Hemmingsen; Monica A Spiteri
Journal:  J Allergy Clin Immunol       Date:  2002-05       Impact factor: 10.793

Review 3.  Pathogenesis and disease mechanisms of occupational asthma.

Authors:  Zana L Lummus; Adam V Wisnewski; David I Bernstein
Journal:  Immunol Allergy Clin North Am       Date:  2011-11       Impact factor: 3.479

4.  Human innate immune responses to hexamethylene diisocyanate (HDI) and HDI-albumin conjugates.

Authors:  A V Wisnewski; Q Liu; J Liu; C A Redlich
Journal:  Clin Exp Allergy       Date:  2008-06       Impact factor: 5.018

5.  The HLA DRB1*1501-DQB1*0602-DPB1*0501 haplotype is a risk factor for toluene diisocyanate-induced occupational asthma.

Authors:  Jeong-Hee Choi; Kyung-Wha Lee; Cheol-Woo Kim; Choon-Sik Park; Hyun-Young Lee; Gyu-Young Hur; Seung-Hyun Kim; Chein-Soo Hong; An-Soo Jang; Hae-Sim Park
Journal:  Int Arch Allergy Immunol       Date:  2009-05-12       Impact factor: 2.749

6.  Is occupational asthma to diisocyanates a non-IgE-mediated disease?

Authors:  Meinir G Jones; Alison Floyd; Kayhan T Nouri-Aria; Mikila R Jacobson; Stephen R Durham; Anthony Newman Taylor; Paul Cullinan
Journal:  J Allergy Clin Immunol       Date:  2006-01-27       Impact factor: 10.793

7.  Hypomethylation of dual specificity phosphatase 22 promoter correlates with duration of service in firefighters and is inducible by low-dose benzo[a]pyrene.

Authors:  Bin Ouyang; C Stuart Baxter; Hung-Ming Lam; Samrat Yeramaneni; Linda Levin; Erin Haynes; Shuk-Mei Ho
Journal:  J Occup Environ Med       Date:  2012-07       Impact factor: 2.162

8.  Quantitative analysis and diagnostic significance of methylated SLC19A3 DNA in the plasma of breast and gastric cancer patients.

Authors:  Enders K O Ng; Candy P H Leung; Vivian Y Shin; Chris L P Wong; Edmond S K Ma; Hong Chuan Jin; Kent-Man Chu; Ava Kwong
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

9.  Maternal exposure to polycyclic aromatic hydrocarbons and 5'-CpG methylation of interferon-γ in cord white blood cells.

Authors:  Wan-yee Tang; Linda Levin; Glenn Talaska; Yuk Yin Cheung; Julie Herbstman; Deliang Tang; Rachel L Miller; Frederica Perera; Shuk-Mei Ho
Journal:  Environ Health Perspect       Date:  2012-05-04       Impact factor: 9.031

10.  Relation of DNA methylation of 5'-CpG island of ACSL3 to transplacental exposure to airborne polycyclic aromatic hydrocarbons and childhood asthma.

Authors:  Frederica Perera; Wan-yee Tang; Julie Herbstman; Deliang Tang; Linda Levin; Rachel Miller; Shuk-mei Ho
Journal:  PLoS One       Date:  2009-02-16       Impact factor: 3.240

View more
  12 in total

Review 1.  Occupational asthma: an overview.

Authors:  Jessica Tan; Jonathan A Bernstein
Journal:  Curr Allergy Asthma Rep       Date:  2014-05       Impact factor: 4.806

Review 2.  Skin and respiratory chemical allergy: confluence and divergence in a hybrid adverse outcome pathway.

Authors:  Ian Kimber; Alan Poole; David A Basketter
Journal:  Toxicol Res (Camb)       Date:  2018-01-26       Impact factor: 3.524

3.  Acute 4,4'-Methylene Diphenyl Diisocyanate Exposure-Mediated Downregulation of miR-206-3p and miR-381-3p Activates Inducible Nitric Oxide Synthase Transcription by Targeting Calcineurin/NFAT Signaling in Macrophages.

Authors:  Chen-Chung Lin; Brandon F Law; Justin M Hettick
Journal:  Toxicol Sci       Date:  2020-01-01       Impact factor: 4.849

4.  Chronic exposure to trichloroethylene increases DNA methylation of the Ifng promoter in CD4+ T cells.

Authors:  Kathleen M Gilbert; Sarah J Blossom; Stephen W Erickson; Brannon Broadfoot; Kirk West; Shasha Bai; Jingyun Li; Craig A Cooney
Journal:  Toxicol Lett       Date:  2016-08-21       Impact factor: 4.372

Review 5.  Blood-borne biomarkers and bioindicators for linking exposure to health effects in environmental health science.

Authors:  M Ariel Geer Wallace; Tzipporah M Kormos; Joachim D Pleil
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2016-10-19       Impact factor: 6.393

Review 6.  Biomarkers in Occupational Asthma.

Authors:  Javier Dominguez-Ortega; Pilar Barranco; Rosa Rodríguez-Pérez; Santiago Quirce
Journal:  Curr Allergy Asthma Rep       Date:  2016-09       Impact factor: 4.806

Review 7.  Clinical implications of interferon-γ genetic and epigenetic variants.

Authors:  Nicola L D Smith; David W Denning
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

8.  Longitudinal Study of DNA Methylation of Inflammatory Genes and Cancer Risk.

Authors:  Brian Thomas Joyce; Tao Gao; Lei Liu; Yinan Zheng; Siran Liu; Wei Zhang; Frank Penedo; Qi Dai; Joel Schwartz; Andrea A Baccarelli; Lifang Hou
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-08-11       Impact factor: 4.254

Review 9.  Epigenetics in immune-mediated pulmonary diseases.

Authors:  Yu Liu; Hui Li; Tao Xiao; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

Review 10.  Epigenomics and allergic disease.

Authors:  Gabrielle A Lockett; Veeresh K Patil; Nelís Soto-Ramírez; Ali H Ziyab; John W Holloway; Wilfried Karmaus
Journal:  Epigenomics       Date:  2013-12       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.